Scroll far enough through social media and you will encounter faces that look subtly — or not so subtly — wrong. Overly shelf-like cheeks, blurred lip borders, a heaviness under the eyes that wasn't there before. In many cases, the culprit is dermal filler migration: product that has moved beyond its intended anatomical placement.
What Is Filler Migration?
Dermal filler migration refers to the displacement of injectable material — most commonly hyaluronic acid (HA) — from the original injection site to adjacent tissue planes.1 While historically considered rare, growing evidence and clinical observation suggest it is far more prevalent than early literature reported, particularly in patients with long cumulative filler histories.2 Importantly, migration does not always cause obvious deformity immediately; product can track along fascial planes over months to years before becoming visible.3
Why Does Filler Move?
HA fillers are hydrophilic — they attract water and can expand significantly after injection. When placed superficially or in highly mobile areas, repeated mechanical forces from facial expression, massage, or even sleeping on the face accelerate displacement.1 The rheological properties of the product matter too: lower-viscosity, more hydrophilic fillers tend to spread more readily than cross-linked, high-G-prime formulations designed for structural support.4
Lips
The most commonly reported migration site. Repeated movement causes product to track superiorly, blurring the vermillion border and creating a "duck lip" shelf.2
Tear Troughs
Thin skin and low-pressure tissue planes make the periorbital area especially prone to filler spread, resulting in festoon-like swelling.3
Nasolabial Folds
Accumulated product over multiple sessions can migrate medially, contributing to a widened, doughy mid-face appearance.5
Jawline
Superficial placement along the mandible may allow product to spread inferiorly or into the neck over time.1
Cumulative volume over time may be a greater risk factor for migration than any single treatment session — a point many patients and practitioners underestimate.
What Can Be Done?
Hyaluronidase — an enzyme that degrades HA — remains the definitive treatment for migrated filler and can be used to selectively dissolve displaced product.6 Results are often dramatic, with resolution in days. Prevention hinges on conservative volumetric approach, appropriate product selection for each anatomical zone, and avoidance of over-treatment across serial sessions. Patients should disclose their full filler history to any treating practitioner and be wary of clinics offering excessively large volumes at single visits.
As demand for non-surgical facial aesthetics continues to grow in Australia and globally, both practitioners and patients benefit from a clearer understanding of filler behaviour over time. An informed approach — prioritising precision over volume — consistently produces the most natural, durable outcomes.
References
- Braz A, Humphrey S, Weinkle S, et al. Lower face: clinical anatomy and regional approaches with injectable fillers. Plast Reconstr Surg. 2015;136(5 Suppl):235S–257S.
- Hwang CJ. Periorbital injectables: understanding and avoiding complications. J Cutan Aesthet Surg. 2016;9(2):73–79.
- Berros P, Labbé D, Elia JP. Overfilling and under-filling: two sides of the same coin. Aesthetic Plast Surg. 2018;42(4):1055–1065.
- Sundaram H, Cassuto D. Biophysical characteristics of hyaluronic acid soft-tissue fillers and their relevance to aesthetic applications. Plast Reconstr Surg. 2013;132(4 Suppl 2):5S–21S.
- Carey W, Weinkle S. Correction of the tear trough deformity with a small-particle hyaluronic acid gel. Dermatol Surg. 2020;46(1):S52–S58.
- DeLorenzi C. Complications of injectable fillers, part 2: vascular complications. Aesthetic Surg J. 2014;34(4):584–600.